Abstract
Staphylococcus species are considered important members of the normal skin microbiota, in addition to being common pathogens in human and animal infections. In addition to S. aureus, other members of the genus are now widely-recognized as pathogens, especially in immunocompromised individuals. One of the most important virulence factors of staphylococci is the formation of biofilm (slime), which enhances their survival on inanimate surfaces, in addition to providing protection against immune cells and antibiotics in vivo. There has been considerable interest in the study of the relationship between biofilm formation and the antibiotic resistant phenotype, however, the results in the available literature are inconsistent. Thus, this study aims to investigate the correlation between biofilm formation and antibiotic resistance in Staphylococcus spp. isolates using phenotypic methods. One hundred and eighty (n = 180) isolates were included in the study, with S. epidermidis (40.0%) and S. lugdunensis (10.0%) being the most numerous. Biofilm-forming capacity was assessed by means of the crystal violet microtiter-plate-based (CV-MTP) method. Methicillin-resistance (MR) was identified in 47.2% (n = 85) of isolates. Among the commonly-used antimicrobials, resistance was highest for clindamycin (51.1%), erythromycin (48.9%) and trimethoprim-sulfamethoxazole (51.1%). Based on the CV-MTP method, n = 13 (7.2%), n = 13 (7.2%), n = 42 (23.3%) and n = 113 (62.3%) staphylococcal isolates were non-biofilm-producing, weak, moderate and strong biofilm producers, respectively. No significant differences in biofilm-formation were shown to be observed on the basis of MR (susceptible (S): 0.881 ± 0.309 vs. resistant (R): 0.890 ± 0.347; p = 0.133) and according to the resistance, to most other antibiotics. Rifampin-resistant isolates were more potent biofilm-producers than their susceptible counterparts (S: 0.802 ± 0.296 vs. R: 1.194 ± 0.221; p = 0.024). The association of the antibiotic-resistant phenotype and biofilm-formation is still inconclusive, due to the heterogeneity of the results in presently available studies; however, the understanding of these mechanisms in Staphylococcus spp. is crucial to appropriately address the therapy and eradication of these pathogens.
Supplementary Materials
The presentation material can be downloaded at: https://www.mdpi.com/article/10.3390/eca2022-12734/s1.
Author Contributions
Conceptualization: M.G.D. and M.G.; Methodology: M.G., M.G.D., M.F. and E.U.; Formal analysis: M.G.D., M.G., M.F., B.Ó. and S.Z.; Investigation: M.F., M.G.D., I.K., S.K.-M.R.R. and M.G.; Resources: Z.B., A.S., V.M. and S.Z.; Supervision: S.Z., E.U.; Project administration: V.M. and M.G.; Funding acquisition: V.M., Z.B. and A.S.; Writing—original draft: M.G.; Writing—review and editing: M.G.D., E.U., I.K., S.K.-M.R.R. and M.G. All authors have read and agreed to the published version of the manuscript.
Funding
M.G. was supported by the János Bolyai Research Scholarship (BO/00144/20/5) of the Hungarian Academy of Sciences. The research was supported by the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research Development and Innovation Fund (M.G.: ÚNKP-22-5-SZTE-107; Ó.B.: ÚNKP-22-2-SZTE-102). M.G. would also like to acknowledge the support of ESCMID’s “30 under 30” Award. The APC was kindly funded by MDPI.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).